Rare diseases
Investigational molecules
Locations
Kleiweg 78, 3051 GV Rotterdam, The Netherlands
Qclinical B.V. in Rotterdam, The Netherlands specialises in clinical trials of conditions such as Influenza, Respiratory syncytial virus infection, Underweight, and other specialisations. This site conducts important research.
The research focus at Qclinical B.V. includes evaluating new therapies for Respiratory syncytial virus (RSV) in adults at high risk of complications, aiming to reduce symptom severity and improve recovery.
This work supports broader efforts to advance respiratory health care across Europe.
Studies at the Rotterdam site explore the potential of ORE-001 (oral lidocaine) to increase food intake and enhance wellbeing in elderly individuals who are underweight, addressing key challenges in nutrition and metabolic health.
These investigations aim to provide safer, effective options for managing malnutrition in vulnerable populations.
More sites in RotterdamThe Netherlands
Clinical trials currently enrolling participants at this site.
Study on the Effects of Oral Lidocaine (ORE-001) on Food Intake in Underweight Elderly Patients
The NetherlandsStudy on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older
The NetherlandsStudy on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection
The NetherlandsGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
